Tech Company Financing Transactions

Atterx BioTherapeutics Funding Round

Atterx BioTherapeutics closed a $3.3 million investment round on 12/14/2006. Investors included Rosetta Partners and Wisconsin Investment Partners.

Transaction Overview

Company Name
Atterx BioTherapeutics
Announced On
12/14/2006
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Undisclosed
Investors

Rosetta Partners (Lead Investor) (Gary Greenwood)

Wisconsin Investment Partners (Thomas Rolfs)

Proceeds Purpose
ConjuGon will use this capital to advance its lead therapeutic, a treatment for the infections of large wounds, into clinical trials and to fund the development and testing of additional therapeutics to combat antibiotic-resistant bacterial infections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 South Rosa Rd. 29
Madison, WI 53719
USA
Phone
(608) 441-2794
Website
www.atterx.com
Email Address
Not Recorded
Overview
Proprietary products for the prevention and treatment of multi-drug resistant Gram negative bacterial infections.
Profile
Atterx BioTherapeutics LinkedIn Company Profile
Social Media
Atterx BioTherapeutics Company Twitter Account
Company News
Atterx BioTherapeutics News
Facebook
Atterx BioTherapeutics on Facebook
YouTube
Atterx BioTherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Paul Evans
  Paul Evans LinkedIn Profile  Paul Evans Twitter Account  Paul Evans News  Paul Evans on Facebook
Chief Executive Officer
Steven Watt
  Steven Watt LinkedIn Profile  Steven Watt Twitter Account  Steven Watt News  Steven Watt on Facebook
Chief Financial Officer
James Millar
  James Millar LinkedIn Profile  James Millar Twitter Account  James Millar News  James Millar on Facebook
Chief Medical Officer
Lisa Ferstenberg
  Lisa Ferstenberg LinkedIn Profile  Lisa Ferstenberg Twitter Account  Lisa Ferstenberg News  Lisa Ferstenberg on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/14/2006: Mode Media venture capital transaction
Next: 12/14/2006: Ophthonix venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to document tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.